Latest filing published 16 Aug 2019 for Mereo BioPharma Group plc, €3,734.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -16.3%Entry US$3.55 · Close at T+365 US$2.97
- -75.0%Entry US$5.05 · Close at T+365 US$1.26
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Charles Sermon: trading record in brief
This profile gathers the share dealings of Charles Sermon in Mereo BioPharma Group plc. We count 4 filings; the first trade dates from 30 April 2019 and the latest from 15 August 2019.
The open-market record is one-sided, with 2 purchases worth €38k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants.
On 16 August 2019 came the latest disclosure, an open-market purchase for €3,734 in Mereo BioPharma Group plc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Charles Sermon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,355 shares@ £0.54100.0% of flowAIMXFCA-NSM:LSE20190816135146_14192519_20200326185057228_19902-0Canonical exit: 13 Nov 2019 (T+90)
- 27,500 sharesOutside of a trading venueFCA-NSM:LSE20190724100812_14161287_20200326185123408_10441-3
- 27,500 sharesOutside of a trading venueFCA-NSM:LSE20190521150839_14082298_20200326185142080_11482-3
- 6,456 shares@ US$6.0090.2% of flowXNMSFCA-NSM:LSE20190501154759_14059895_20200326185143203_28677-1Canonical exit: 29 Jul 2019 (T+90)
4 of 4 declarations
